As of 2025-07-06, the Intrinsic Value of Vivoryon Therapeutics NV (VVY.AS) is -3.94 EUR. This VVY.AS valuation is based on the model Peter Lynch Fair Value. With the current market price of 1.47 EUR, the upside of Vivoryon Therapeutics NV is -368.35%.
Based on its market price of 1.47 EUR and our intrinsic valuation, Vivoryon Therapeutics NV (VVY.AS) is overvalued by 368.35%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -3.94 - -3.94 | -3.94 | -368.35% |
| P/E | (12.07) - (5.05) | (10.71) | -828.6% |
| DDM - Stable | (9.74) - 582.04 | 286.15 | 19366.0% |
| DDM - Multi | (6.84) - 335.26 | (14.35) | -1076.4% |
| Market Cap (mil) | 38.32 |
| Beta | 1.11 |
| Outstanding shares (mil) | 26.07 |
| Enterprise Value (mil) | 29.06 |
| Market risk premium | 5.10% |
| Cost of Equity | 6.77% |
| Cost of Debt | 5.00% |
| WACC | 6.77% |